NM_004456.5:c.396T>C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_004456.5(EZH2):​c.396T>C​(p.Pro132Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00575 in 1,596,652 control chromosomes in the GnomAD database, including 40 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0045 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0059 ( 35 hom. )

Consequence

EZH2
NM_004456.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.881

Publications

4 publications found
Variant links:
Genes affected
EZH2 (HGNC:3527): (enhancer of zeste 2 polycomb repressive complex 2 subunit) This gene encodes a member of the Polycomb-group (PcG) family. PcG family members form multimeric protein complexes, which are involved in maintaining the transcriptional repressive state of genes over successive cell generations. This protein associates with the embryonic ectoderm development protein, the VAV1 oncoprotein, and the X-linked nuclear protein. This protein may play a role in the hematopoietic and central nervous systems. Multiple alternatively splcied transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Feb 2011]
EZH2 Gene-Disease associations (from GenCC):
  • Weaver syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 7-148829816-A-G is Benign according to our data. Variant chr7-148829816-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 359286.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.881 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0045 (686/152282) while in subpopulation NFE AF = 0.00594 (404/68016). AF 95% confidence interval is 0.00546. There are 5 homozygotes in GnomAd4. There are 329 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 686 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004456.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EZH2
NM_004456.5
MANE Select
c.396T>Cp.Pro132Pro
synonymous
Exon 5 of 20NP_004447.2
EZH2
NM_001203247.2
c.396T>Cp.Pro132Pro
synonymous
Exon 5 of 20NP_001190176.1
EZH2
NM_001203248.2
c.369T>Cp.Pro123Pro
synonymous
Exon 5 of 20NP_001190177.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EZH2
ENST00000320356.7
TSL:1 MANE Select
c.396T>Cp.Pro132Pro
synonymous
Exon 5 of 20ENSP00000320147.2
EZH2
ENST00000460911.5
TSL:1
c.396T>Cp.Pro132Pro
synonymous
Exon 5 of 20ENSP00000419711.1
EZH2
ENST00000350995.6
TSL:1
c.279T>Cp.Pro93Pro
synonymous
Exon 4 of 19ENSP00000223193.2

Frequencies

GnomAD3 genomes
AF:
0.00451
AC:
686
AN:
152164
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000917
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00367
Gnomad ASJ
AF:
0.0147
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.0105
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00594
Gnomad OTH
AF:
0.00621
GnomAD2 exomes
AF:
0.00525
AC:
1275
AN:
242642
AF XY:
0.00530
show subpopulations
Gnomad AFR exome
AF:
0.000687
Gnomad AMR exome
AF:
0.00245
Gnomad ASJ exome
AF:
0.0117
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0107
Gnomad NFE exome
AF:
0.00656
Gnomad OTH exome
AF:
0.00741
GnomAD4 exome
AF:
0.00588
AC:
8495
AN:
1444370
Hom.:
35
Cov.:
27
AF XY:
0.00585
AC XY:
4203
AN XY:
718682
show subpopulations
African (AFR)
AF:
0.00104
AC:
34
AN:
32848
American (AMR)
AF:
0.00288
AC:
124
AN:
43010
Ashkenazi Jewish (ASJ)
AF:
0.0134
AC:
348
AN:
25936
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39394
South Asian (SAS)
AF:
0.00263
AC:
220
AN:
83586
European-Finnish (FIN)
AF:
0.0115
AC:
604
AN:
52542
Middle Eastern (MID)
AF:
0.00139
AC:
8
AN:
5736
European-Non Finnish (NFE)
AF:
0.00612
AC:
6739
AN:
1101488
Other (OTH)
AF:
0.00699
AC:
418
AN:
59830
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
363
726
1090
1453
1816
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
266
532
798
1064
1330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00450
AC:
686
AN:
152282
Hom.:
5
Cov.:
32
AF XY:
0.00442
AC XY:
329
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.000914
AC:
38
AN:
41562
American (AMR)
AF:
0.00366
AC:
56
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0147
AC:
51
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00228
AC:
11
AN:
4828
European-Finnish (FIN)
AF:
0.0105
AC:
111
AN:
10606
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00594
AC:
404
AN:
68016
Other (OTH)
AF:
0.00614
AC:
13
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
39
78
118
157
196
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00596
Hom.:
0
Bravo
AF:
0.00458
Asia WGS
AF:
0.00145
AC:
5
AN:
3470

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

EZH2: BP4, BP7, BS2

EZH2-related disorder Benign:1
Apr 10, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Weaver syndrome Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.57
CADD
Benign
8.3
DANN
Benign
0.57
PhyloP100
-0.88
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61732845; hg19: chr7-148526908; API